Hyperhomocysteinemia in terms of steady-state kinetics

被引:52
|
作者
Refsum, H [1 ]
Guttormsen, AB [1 ]
Fiskerstrand, T [1 ]
Ueland, PM [1 ]
机构
[1] Univ Bergen, Dept Pharmacol, N-5021 Bergen, Norway
关键词
Hcy homocysteine and/or its oxidized products; k rate constant for elimination; tHcy total homocysteine; T-1/2 elimination half-life;
D O I
10.1007/PL00014303
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The plasma level of homocysteine (Hcy) and its oxidized products, i.e., plasma total Hcy (tHcy), is a function of the influx rate of Hey to plasma and the plasma tHcy clearance. In vitro experiments show that proliferating cells usually export more Hcy than stationary cells and that the Hcy export increases in response to high methionine, low folate or low cobalamin level, and to agents interfering with Hcy remethylation. Comparison between various cell types suggests that hepatocytes have a unique ability to increase the Hcy export in response to extracellular methionine, probably due to its capacity to form adenosylmethionine. Some but not all cell types have an ability to use extracellular Hey as a methionine source. Clearance studies in healthy subjects indicate that about 1.2 mmol Hey is supplied from the cells to plasma per 24 h, which is only about 5-10% of total Hcy formed. Comparison of area under the curves after administration of Hcy and methionine shows that about 10% of the methionine administered is released to plasma as Hcy. Notably, only a few percent of Hey from plasma is excreted unchanged in the urine, and this shows that most tHcy in plasma is metabolized. Folate or cobalamin deficient patients have normal plasma tHcy clearance, which suggests that their elevated tHcy level is due to increased Hey export from tissues into the plasma compartment. In contrast, the hyperhomocysteinemia in renal failure is accounted for by a marked reduction in tHcy clearance, suggesting an important role of kidney in elimination of Hcy from plasma.
引用
收藏
页码:S45 / S49
页数:5
相关论文
共 50 条
  • [31] STEADY-STATE KINETICS OF VALPROIC ACID IN EPILEPTIC PATIENTS
    BRUNI, J
    WILDER, BJ
    WILLMORE, LJ
    PERCHALSKI, RJ
    VILLARREAL, HJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1978, 24 (03) : 324 - 332
  • [32] EFFECT OF VENTRICULAR FAILURE ON STEADY-STATE KINETICS OF MEXILETINE
    LEAHEY, EB
    GIARDINA, EGV
    BIGGER, JT
    CLINICAL RESEARCH, 1980, 28 (02): : A239 - A239
  • [33] REGULATORY ROLE OF ENZYME ISOMERIZATION IN STEADY-STATE KINETICS
    SAIFULLIN, SR
    MOLECULAR BIOLOGY, 1990, 24 (05) : 1027 - 1035
  • [34] KINETICS OF CONTACT FUSION UNDER STEADY-STATE CONDITIONS
    TEMKIN, DE
    RUSSIAN METALLURGY-METALLY-USSR, 1967, (03): : 107 - &
  • [35] SATURATION KINETICS FOR STEADY-STATE PULMONARY CO TRANSFER
    MENDOZA, C
    PEAVY, H
    BURNS, B
    GURTNER, G
    JOURNAL OF APPLIED PHYSIOLOGY, 1977, 43 (05) : 880 - 884
  • [36] STEADY-STATE KINETICS OF SUSTAINED-RELEASE PHENYLPROPANOLAMINE
    LONNERHOLM, G
    GRAHNEN, A
    LINDSTROM, B
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1984, 22 (01) : 39 - 41
  • [37] LISINOPRIL STEADY-STATE KINETICS IN HEALTHY-SUBJECTS
    BEERMANN, B
    JUNGGREN, I
    COCCHETTO, D
    CIRILLO, VJ
    GOMEZ, HJ
    HICHENS, M
    TILL, AE
    BOLOGNESE, JA
    JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 25 (06): : 471 - 471
  • [38] KINETICS AND DYNAMICS OF TRIAMTERENE AT STEADY-STATE IN PATIENTS WITH CIRRHOSIS
    DAO, MT
    VILLENEUVE, JP
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1988, 11 (01): : 6 - 9
  • [39] STEADY-STATE KINETICS OF THE CATALASE REACTION IN THE PRESENCE OF CYANIDE
    OGURA, Y
    YAMAZAKI, I
    JOURNAL OF BIOCHEMISTRY, 1983, 94 (02): : 403 - 408
  • [40] STEADY-STATE AND EQUILIBRIUM APPROXIMATIONS IN REACTION-KINETICS
    VOLK, L
    RICHARDSON, W
    LAU, KH
    HALL, M
    LIN, SH
    JOURNAL OF CHEMICAL EDUCATION, 1977, 54 (02) : 95 - 97